EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Hematological and Inflammatory Markers in Isotretinoin-Associated Sacroiliitis: A Prospective Cohort Study

Nurcan Metin, Çağrı Turan, Enes Kirik, Zeynep Karaca Ural, Saime Özbek Şebin

Dermatology Practical & Conceptual · 2026-10-29 · 16 (4) · 7274

DOI: 10.5826/dpc.1604a7274 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Low back pain (LBP) and sacroiliitis have been reported during isotretinoin therapy, but the role of inflammatory markers in identifying sacroiliitis remains unclear. Objectives: This study aimed to determine the frequency of LBP and sacroiliitis during isotretinoin therapy and investigate whether any hematological or inflammatory parameter could help identify magnetic resonance imaging (MRI)-confirmed sacroiliitis. Methods: This prospective cohort study included 220 patients receiving isotretinoin for moderate-to-severe acne. Patients reporting pain at rest or morning stiffness lasting longer than one hour were referred for MRI. Hematological and inflammatory parameters, including C-reactive protein erythrocyte sedimentation neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), monocyte-to–high-density lipoprotein ratio (MHR), red blood cell distribution width (RDW)-to-lymphocyte and RDW-to-platelet ratio, systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI) were compared among patients with MRI-confirmed sacroiliitis, MRI-negative inflammatory LBP, and no LBP. Results: LBP occurred in 81 patients (36.8%); 59 (26.8%) met the study-defined inflammatory pain criteria, and 22 (10.0%) had mechanical pain. Six MRI-eligible patients declined imaging. Sacroiliitis was identified in 22 patients, representing 10.0% of the enrolled cohort, 10.3% after excluding MRI refusals. No significant between-group differences were observed in the evaluated hematological or inflammatory parameters (all p>0.05). Conclusions: Isotretinoin-associated sacroiliitis occurs with notable frequency. The evaluated markers did not differ significantly among the groups. Clinical assessment and MRI may be more informative than inflammatory markers in distinguishing isotretinoin-associated sacroiliitis from MRI-negative inflammatory LBP. Further studies are needed to establish their diagnostic utility and investigate alternative biomarkers for identifying isotretinoin-associated sacroiliitis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →